Research
Hormonal
Weekly subcutaneous semaglutide (2.4 mg) produces significant weight loss (approx. 15%) and improves cardiovascular outcomes in adults with overweight or obesity, including those with heart failure with preserved ejection fraction (HFpEF).
If you have obesity, weekly semaglutide injections (2.4 mg) can help you lose about 15% of your body weight and significantly lower your risk of heart problems. This treatment is safe and effective for long-term use, unlike older drugs that were banned for causing heart issues.
StrongSupportsVERY_HIGH confidence
Incretin-based obesity treatments are making remarkable progress... significantly improving complications associated with obesity, such as cardiovascular diseases... Semaglutide 2.4 mg... showed a 15.2% weight loss... and the SELECT study demonstrated a 20% reduction in major cardiovascular events.
Why this rating
Based on multiple large-scale Phase 3 trials (STEP 1-8, SELECT) with robust statistical significance.
Source
Recent Progression of Incretin-Based Obesity Treatment
Dughyun Choi · Korean Journal of Medicine · 2024
DOI 10.3904/kjm.2024.99.2.78
narrative_review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →